Oncode Institute receives green light for next phase

Oncode Institute will continue for another 5 years, starting January 1, 2023. Eighteen of NKI’s research groups are part of this virtual fundamental cancer research institute, which can now continue its mission thanks to a follow-up investment of 92 million euros. Group leader Karin de Visser: “Thanks to Oncode, we have established new collaborations through which we were able to initiate novel high-risk projects.”